Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.

Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference3%
- Check24 days agoChange Detected- Added version label v3.1.0. - Removed the resource entry for Plasma cell myeloma from Genetic and Rare Diseases Information Center.SummaryDifference0.4%
- Check39 days agoChange DetectedUpgrade to Revision: v3.0.2, replacing v3.0.1. The 'Back to Top' element was removed as a minor UI change.SummaryDifference0.2%
- Check46 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check53 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new medical terms and compounds related to plasma cell myeloma and various chemical classifications. Notably, several previous entries related to multiple myeloma and specific drug formulations have been removed.SummaryDifference6%
- Check67 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.1%
Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.